Why are vaccines still important if so many kids have already had COVID-19?

A recent CDC report estimated that 75% of U.S. kids have likely had COVID-19. Here’s why experts say vaccines are still important, despite having recovered from a previous infection.

Milwaukee VA COVID vaccine mandate, unvaccinated nurses worry

"A disservice to our country" is how unvaccinated nurses at the Milwaukee VA Medical Center describe enforcement of a COVID vaccine mandate which could result in staff losing their jobs.

Appeals court OKs Biden's federal employee COVID-19 vaccine mandate

In a 2-1 ruling, a panel of the 5th Circuit Court of Appeals in New Orleans reversed a lower court and ordered dismissal of a lawsuit challenging the mandate.

COVID-19 vaccine second booster: Who needs one and when?

The Food and Drug Administration authorized a second COVID-19 booster for many Americans. Here's a look at who is eligible and when to get it.

COVID vaccine: 2nd booster recommended, doctors say

The CDC released new recommendations for second COVID-19 vaccine boosters, approved by the FDA for vulnerable populations.

Pfizer seeks approval for 4th COVID-19 booster dose for seniors

Pfizer is expected to request authorization for a fourth COVID-19 vaccine dose for seniors in a move to provide extra protection to the over-65 population that has been hit hardest by the pandemic.

Exercise after COVID-19 vaccine may increase antibodies, study finds

The study demonstrates that 90 minutes of exercise after immunization of the COVID-19 vaccine increases antibody response several weeks later.

Pfizer shot offers nearly no protection against infection in 5- to 11-year-olds

Pfizer's COVID-19 vaccine is effective at preventing hospitalization in children 5 to 11 but offers virtually no protection against infection, even just a month after full immunization.

COVID-19 vaccines in pregnant women may protect newborns, study shows

The study showed the completion of vaccination during pregnancy was associated with reduced risk for COVID-19-associated hospitalizations in newborn babies.

AstraZeneca acquires 'modest' profit of $4B from COVID-19 vaccine sales

The Anglo-Swedish drugmaker said in November it would begin to take a “modest” profit from the COVID-19 shot, which it had been providing “at cost.”